FIELD: chemistry.
SUBSTANCE: invention relates to biochemistry. Described is a group of inventions comprising a polypeptide suitable for inducing an immune response to PCV2 virus, a recombinant cell comprising a nucleic acid molecule encoding said polypeptide, a nucleic acid, vector containing nucleic acid, recombinant swinepox virus containing in its genome nucleic acid, composition, vaccine, use of a polypeptide, a cell and nucleic acid for preparing a drug for treating or preventing PCV2-associated disease in a pig. In one embodiment, the polypeptide comprises a peptide for addressing to a cell membrane with length of not more than 50 amino acids of the sequence SEQ ID NO: 1 or a sequence having at least 95 % identity with respect to SEQ ID NO: 1.
EFFECT: invention extends the range of agents for inducing an immune response to PCV2 virus.
20 cl, 4 dwg, 1 tbl, 6 ex
Authors
Dates
2019-09-02—Published
2014-04-10—Filed